The Postoperative Head Position as a Predictor of the Surgical Outcome After DMEK
NCT ID: NCT04387331
Last Updated: 2020-05-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
50 participants
OBSERVATIONAL
2020-05-11
2021-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Investigation of Different Scanning Protocols for 3 Dimensional High-resolution Imaging of the Human Cornea With Optical Coherence Tomography (OCT) - A Pilot Study
NCT01843101
The Effects of Regular Eye-training With a Mobile Device on Adult Patients With AMD
NCT03461393
The Viability Control of Human Endothelial Cells Before Keratoplasty (V-CHECK) Study
NCT05847387
Quantification of Metamorphopsia in Patients With Epiretinal Membranes
NCT05138315
Objective Evaluation of the Effect of Oculoplastic Operations Using the Vectra M 3D Imaging System
NCT06040671
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In this study, the participants head position will be continuously monitored within the first three days after DMEK. Participants wear a headband in which a small sensor is inserted. The degree of deviation from the neutral position will then be correlated with clinical outcomes.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institut für Angewandte Trainingswissenschaft
UNKNOWN
Peter Wiedemann
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Peter Wiedemann
Director
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Peter Wiedemann, MD
Role: STUDY_DIRECTOR
University of Leipzig
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Leipzig University Hospital, Department of Ophthalmology
Leipzig, Saxony, Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
287/19-ek
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.